Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Alzamend Neuro, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 21 | 17 | −4 |
| Shares | 3.09M | 7.94M | +4.84M (+156.6%) |
| Value | $2.70M | $9.41M | +$6.71M (+248.9%) |
New holders (5)
Institutions that held Alzamend Neuro, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 596,129 | $709.0K | 0.00% |
| Northern Trust Corp | 42,911 | $51.0K | 0.00% |
| Dark Forest Capital Management LP | 11,344 | $13.0K | 0.00% |
| Benjamin Edwards Inc | 1,000 | $1.00K | 0.00% |
| Wells Fargo & Company | 380 | $0 | 0.00% |
Sold out (9)
Institutions that held Alzamend Neuro, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 101,646 | $88.0K |
| Susquehanna International Group, LLP | 83,950 | $73.0K |
| Renaissance Technologies LLC | 65,131 | $56.0K |
| Millennium Management LLC | 49,223 | $43.0K |
| Kingsbury Capital Investment Advisors LLC | 25,059 | $22.0K |
| Two Sigma Securities, LLC | 15,458 | $13.0K |
| Tower Research Capital LLC (TRC) | 15,266 | $13.0K |
| Citigroup Inc | 2,000 | $2.00K |
| Simplex Trading, LLC | 2,701 | $2.00K |